Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

NCT00826540 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Colon Cancer
Recurrent Rectal Cancer
Stage IV Colon Cancer
Stage IV Rectal Cancer

Interventions

DRUG: sorafenib tosylate
BIOLOGICAL: bevacizumab

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]